ICRM
CLVS

Insight Capital Research & Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Insight Capital Research & Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,757
Closed -$820K – 146
2017
Q2 		$820K Buy
+8,757
New +$536K 0.48% 85
2013
Q3 		– Sell
-17,528
Closed -$1.17M – 222
2013
Q2 		$1.17M Buy
+17,528
New +$788K 0.3% 99

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Insight Capital Research & Management's CLVS Position: Q3 2017 in Review

Insight Capital Research & Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2017, closing a stake of 8,757 shares — an estimated $820K sold.

Insight Capital Research & Management first reported a position in CLVS in Q2 2013 and held it in 2 quarters. The position peaked at $1.17M in Q2 2013. 255 funds tracked by Wall St. Rank hold CLVS as of Q3 2017.

  • Insight Capital Research & Management reported no remaining Clovis Oncology, Inc. position as of Q3 2017 after selling out during the quarter.
  • Insight Capital Research & Management sold 8,757 Clovis Oncology, Inc. shares in Q3 2017, an estimated $820K.
  • Insight Capital Research & Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 2 quarters.
  • Insight Capital Research & Management's Clovis Oncology, Inc. position peaked at $1.17M in Q2 2013.
  • 255 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2017.

Based on Insight Capital Research & Management's 13F filing for Q3 2017, filed 15 Nov 2017.